Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial of Treatment of Poor-Prognosis IgA Nephropathy With Low Exposure to Sirolimus.

NCT00396721 is registered in ClinicalTrials.gov with Josep m Cruzado as lead sponsor.

NCT NCT00396721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00396721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial of Treatment of Poor-Prognosis IgA Nephropathy With Low Exposure to Sirolimus.
Lead sponsor
Josep m Cruzado
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2006
Completion date
February 28, 2010
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glomerulonephritis, iga, iga nephropathy, nephropathy, iga